Abzena, an end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has appointed Moncef Slaoui, PhD, to its Board of Directors. An accomplished leader in the biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback